Optimization, scale-up, stability, and manufacture of a hydrogel for local, sustained delivery - phase I

用于局部持续递送的水凝胶的优化、放大、稳定性和制造——第一阶段

• 批准号: 493938-2016
• 负责人: Shoichet, Molly
• 金额: $ 8.92万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=602924
• 关键词: Optimization; scale; up; stability; manufacture

Hammock Therapeutics is a Toronto-based biotechnology company focused on developing and commercializing a unique hydrogel platform technology for medical applications. Hammock Therapeutics represents a unique opportunity for the commercialization of combination products at the interface of biomaterials and pharmaceuticals. The lead program for the company is to develop a product to overcome post-operative pain, an unmet clinical and market need with a clear path to market.

Hammock Therapeutics是一家总部位于多伦多的生物技术公司，专注于开发和商业化用于医疗应用的独特水凝胶平台技术。Hammock Therapeutics为生物材料和药物界面的组合产品商业化提供了独特的机会。该公司的主要计划是开发一种产品来克服术后疼痛，这是一种未满足的临床和市场需求，具有明确的市场路径。